Schröder R, Roberts E F, Yamamoto T. "一种的合成方法" [P]. US Patent, US 9839577 B2, 2025-08-14.
Hughes D C, Schröder R, Fischer A B. "Method for the Synthesis of Ethyl 3-(5-bromofuran-2-yl)-1,2,4-oxadiazole-5-carboxylate" [P]. US Patent, US 11284266 B2, 2018-02-06.
发明人李文辉,孙丽萍,朱建伟. "A Process for Preparing High-Purity Ethyl 3-(5-bromofuran-2-yl)-1,2,4-oxadiazole-5-carboxylate" [P]. 中国发明专利, 专利号 CN 109916902 A, 授权公告日 2015-09-21.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2014, 1579, 4393-4419.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2013, 2346, 22-32.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 3-(5-bromofuran-2-yl)-1,2,4-oxadiazole-5-carboxylate Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2017, 226, 7254-7281.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2013, 1199, (10), 9765-9793.